Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMAZE Cohort 2: ZYNRELEF in Abdominoplasty
NCT06109428Phase 4Completed
- Sponsor
- Heron Therapeutics, Inc.
- Start
- Oct 2021
- Primary completion
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of bupivacaine + meloxicam in postoperative pain, sponsored by Heron Therapeutics, Inc.. Started Oct 2021; status: completed.
02
Drugs
bupivacaine + meloxicam
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06109428.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06109428.